Omicron B.A 2: Vaccine Construction with MHC Class-I, MHC Class-II by Using Bioinformatics Tools
Archives of Immunology Research and Therapy · 2024
DOI: 10.58489/2836-5003/011 ↗Kurz gefasst
Fachartikel in der Zeitschrift Archives of Immunology Research and Therapy, 2024. Verfasst von Muhammad Waqar Mazhar.
Abstract (Originalsprache)
SARS (COV-2) was recognized in 31/December/2019 in Wuhan city in the Hubei Provence of China. The omicron variant of COVID-19 reported in November 2021. Omicron can have many earlier documented mutations of other variant of concern (VOC) omicron is including 32 mutations of spike like protein, it is too compared of the 16 mutations. The omicron variant has been divided into four linages BA.1, BA.2, BA.3, B.1.1.529. BA.1 which could destroyed our immune system and vaccine are not highly effective against BA.2.
Zitieren
APA
Mazhar, M. W. (2024). Omicron B.A 2: Vaccine Construction with MHC Class-I, MHC Class-II by Using Bioinformatics Tools. Archives of Immunology Research and Therapy. https://doi.org/10.58489/2836-5003/011
Vancouver
Mazhar MW. Omicron B.A 2: Vaccine Construction with MHC Class-I, MHC Class-II by Using Bioinformatics Tools. Archives of Immunology Research and Therapy. 2024. doi:10.58489/2836-5003/011
BibTeX
@article{Mazhar2024,
author = {Mazhar, Muhammad Waqar},
title = {Omicron B.A 2: Vaccine Construction with MHC Class-I, MHC Class-II by Using Bioinformatics Tools},
journal = {Archives of Immunology Research and Therapy},
year = {2024},
doi = {10.58489/2836-5003/011}
}
EUVIMED